trending Market Intelligence /marketintelligence/en/news-insights/trending/5gsmq6trurfjqw9n_bz38w2 content esgSubNav
In This List

ObsEva to seek listing on Swiss stock exchange

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


ObsEva to seek listing on Swiss stock exchange

Swiss biopharmaceutical company ObsEva SA said it plans to list its stock on the SIX Swiss Exchange.

The company, which sold shares on the Nasdaq market last year, said it plans to list in Switzerland to raise its profile with European investors for future potential financing.

The listing will also help provide the company's shareholders with the protection offered by the Swiss takeover rules, ObsEva said in a statement.

The company also plans to maintain its listing on the Nasdaq Global Select Market.

ObsEva reported in February 2018 that its infertility treatment met the main goal of a late-stage study.